Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study - Marabelle, A; Le, D T; Ascierto, P A (J Clin Oncol, 2020)
et al.